Explore the challenges faced by Indian pharma in developing rare disease drugs and potential solutions for innovation and cost reduction.
The Centers for Medicare & Medicaid Services Dec. 23 introduced a new drug pricing model, BALANCE, for Medicare Part D and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback